Canada Life
KYMR icon

Canada Life’s Kymera Therapeutics KYMR Stock Holding History

Canada Life’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$445K Buy
5,310
+1,379
+35% +$109K ﹤0.01% 1517
2025
Q4 		$306K Sell
3,931
-6,560
-63% -$443K ﹤0.01% 1573
2025
Q3 		$614K Hold
10,491
– – ﹤0.01% 1564
2025
Q2 		$458K Hold
10,491
– – ﹤0.01% 1625
2025
Q1 		$288K Hold
10,491
– – ﹤0.01% 1691
2024
Q4 		$422K Hold
10,491
– – ﹤0.01% 1669
2024
Q3 		$497K Hold
10,491
– – ﹤0.01% 1671
2024
Q2 		$313K Buy
10,491
+6,560
+167% +$227K ﹤0.01% 1766
2024
Q1 		$158K Hold
3,931
– – ﹤0.01% 1865
2023
Q4 		$99K Buy
3,931
+2,287
+139% +$40.9K ﹤0.01% 1950
2023
Q3 		$23K Hold
1,644
– – ﹤0.01% 2108
2023
Q2 		$38K Hold
1,644
– – ﹤0.01% 2035
2023
Q1 		$49K Hold
1,644
– – ﹤0.01% 2071
2022
Q4 		$41K Hold
1,644
– – ﹤0.01% 2114
2022
Q3 		$36K Hold
1,644
– – ﹤0.01% 2160
2022
Q2 		$32K Hold
1,644
– – ﹤0.01% 2159
2022
Q1 		$74K Buy
1,644
+392
+31% +$16.6K ﹤0.01% 2074
2021
Q4 		$79K Buy
1,252
+507
+68% +$29.5K ﹤0.01% 2063
2021
Q3 		$44K Hold
745
– – ﹤0.01% 2266
2021
Q2 		$36K Hold
745
– – ﹤0.01% 2357
2021
Q1 		$29K Hold
745
– – ﹤0.01% 2448
2020
Q4 		$46K Buy
+745
New +$36.3K ﹤0.01% 2307

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Canada Life's KYMR Position: Q1 2026 in Review

Canada Life increased its Kymera Therapeutics (KYMR) stake by 35% in Q1 2026, buying an estimated $109K and bringing the position to 5,310 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.

Canada Life first reported a position in KYMR in Q4 2020 and has held it in 22 quarters since. The position peaked at $614K in Q3 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Canada Life held 5,310 shares of Kymera Therapeutics worth $445K as of Q1 2026.
  • Canada Life bought 1,379 Kymera Therapeutics shares in Q1 2026, an estimated $109K.
  • Kymera Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1517 holding.
  • Canada Life first reported a position in Kymera Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Canada Life's Kymera Therapeutics position peaked at $614K in Q3 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.